AZ-AAV9

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAZ-AAV9
Drug Alias NameAlzheimers disease gene therapy (RegenX Biosciences)adeno-associated virus vector-9 based gene therapy (RegenX Biosciences)AZ-AAV9
ClassificationBiologics
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRegenxbio Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRegenxbio Inc
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A